Skip to main content
Clinical Trials/NCT02062177
NCT02062177
Completed
Phase 4

Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy: a Randomized Double Blind Controlled Study

Università Vita-Salute San Raffaele1 site in 1 country140 target enrollmentFebruary 2014

Overview

Phase
Phase 4
Intervention
Propofol
Conditions
Sedation
Sponsor
Università Vita-Salute San Raffaele
Enrollment
140
Locations
1
Primary Endpoint
Endoscopist's Satisfaction (Visual Analog Scale) About Sedation
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Many studies address safety of non-anesthesiologist propofol sedation (NAPS) for gastrointestinal endoscopy. Target Controlled Infusion (TCI) is a sophisticated tool for providing optimal sedation regimen and avoiding under or oversedation. The objective of the study is to compare standard moderate sedation during upper endoscopy and colonoscopy versus propofol NAPS.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
May 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Testoni Pier Alberto

Professor

Università Vita-Salute San Raffaele

Eligibility Criteria

Inclusion Criteria

  • age \< 18 years
  • American Society of Anesthesiologists risk I-II
  • patients undergoing to Gastroscopy or Colonoscopy

Exclusion Criteria

  • significant systemic disease
  • allergic reactions to any of study drugs
  • chronic use of opioids or psychiatric disorders
  • pregnancy
  • Mallampati score \> 2
  • age \< 18 years

Arms & Interventions

propofol group

70 patients (35 upper endoscopy - 35 colonoscopy)

Intervention: Propofol

midazolam group

70 patients (35 upper endoscopy - 35 colonoscopy)

Intervention: Midazolam

Outcomes

Primary Outcomes

Endoscopist's Satisfaction (Visual Analog Scale) About Sedation

Time Frame: at the end of the exam

Visual Analog Scale from 0 to100 (0=dissatisfaction - 100=complete satisfaction) will be used to assess the technical difficulty of examination and the satisfaction with sedation of patient experienced by endoscopist

Patient's Satisfaction (Visual Analog Scale) About Sedation 24-72 Hours After Procedure

Time Frame: at 24-72 hours after procedure

Patients will be contacted by telephone 24-72 hours after discharge and asked about their satisfaction about the quality of sedation, rated on a verbal rating scale, from 0 to 100 (0=dissatisfaction; 100=complete satisfaction)

Patient's Satisfaction (Visual Analog Scale) About Sedation Before Discharge

Time Frame: before discharge

When completely awake, patients will be asked to rate the degree of pain/discomfort and the degree of satisfaction about quality of sedation from 0 to100 (0=dissatisfaction - 100=complete satisfaction)

Secondary Outcomes

  • Number of Participants With Adverse Events as a Measure of Safety(one day)
  • Time (Minutes) to Dischargeability of Patient From Endoscopic Unit(one day)

Study Sites (1)

Loading locations...

Similar Trials